BCI Revolution: Wearable Tech Pushing Human Enhancement?
BCI Revolution: Wearable Tech Pushing Human Enhancement?
Brain-computer interfaces are evolving rapidly, moving beyond invasive surgeries. New players like Bridge Neurotech are betting on wearable ultrasound technology, aiming to make mind-machine connections accessible to eve
The realm of human enhancement is on the cusp of its next major leap, and it’s arriving in the form of brain-computer interfaces (BCIs). Forget science fiction - merging mind and machine is no longer a distant dream, but a rapidly approaching reality that’s becoming increasingly accessible.
The Surgical Frontier
For years, the conversation around BCIs has largely centered on implanted devices. Companies like Elon Musk's Neuralink, along with Synchron, Paradromics, and Precision Neuroscience, have focused on systems that require neurosurgery to translate brain signals into useful actions, helping individuals who have lost the ability to move or speak.
These devices record electrical impulses directly from neurons, enabling paralyzed individuals to control electronic devices, robotic arms, and even communicate in real time with their thoughts.
However, this approach comes with significant barriers.
As Will Biederman, founder and CEO of the new startup Bridge Neurotech, succinctly puts it, “Nobody really wants a hole in their head.” Only around 100 people globally have received implanted BCIs in clinical trials, underscoring the high bar for safety and benefit these devices must clear given the inherent risks of surgery.
Biederman, who developed the chip Neuralink licensed for its early devices, has struck out with a different vision entirely.
The Rise of Wearable BCIs
Enter Bridge Neurotech, a company launching with $13.5 million in funding, including from venture firm General Catalyst. Their goal is to revolutionize the BCI landscape by building a wearable, non-invasive brain-computer interface. This shift is critical: imagine a device that offers similar capabilities without the need for a scalpel.
It fundamentally changes the potential user base from a specialized medical application to a broader consumer market.
Bridge Neurotech isn't alone in this pursuit. Sam Altman-backed Merge Labs is another key player, also exploring non-invasive methods. Both companies share ties to Arbor Neuroscience (formerly Forest Neurotech), an organization focused on integrated, long-horizon neurotech research.
The common thread here is ultrasound technology. Instead of electrical signals, ultrasound uses high-frequency sound waves to measure blood flow in the brain. Since fluctuations in blood flow closely follow neural activity, it offers an indirect way to monitor brain function.
The Ultrasound Advantage (and Challenge)
While ultrasound sidesteps surgery, it presents its own set of challenges, primarily signal latency. Maryam Shanechi, a neuroengineer at the University of Southern California, explains,
It captures a slower variation in neural activity. That's fine for a lot of applications, but it depends what you want to build.
There's a natural delay of a few seconds between neural firing and the subsequent change in blood flow.
For real-time, fast-paced tasks like controlling a robotic limb or rapid typing, this lag could be problematic.
Bridge Neurotech is tackling this head-on by planning to use predictive AI models to significantly reduce this lag and boost performance. This fusion of ultrasound and advanced artificial intelligence could be the key to unlocking the full potential of wearable BCIs for both medical and consumer applications.
With Bridge Neurotech starting its first observational clinical study in Redwood City, California, we're watching a pivotal moment unfold in the journey toward a future where enhancing our minds might be as simple as wearing a cap or headband.
